Peptidic sulfonamides

Details for Australian Patent Application No. 2004208865 (hide)

Owner Merck Patent GmbH

Inventors Jonczyk, Alfred; Zischinsky, Gunther; Groth, Ulrich

Agent Davies Collison Cave

Pub. Number AU-B-2004208865

PCT Pub. Number WO2004/069861

Priority 03002556.3 06.02.03 EP

Filing date 14 January 2004

Wipo publication date 19 August 2004

Acceptance publication date 17 June 2010

International Classifications

C07K 7/06 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

22 September 2005 PCT application entered the National Phase

  PCT publication WO2004/069861 Priority application(s): WO2004/069861

17 June 2010 Application Accepted

  Published as AU-B-2004208865

14 October 2010 Standard Patent Sealed

9 August 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004208870-Novel substituted 2-aminoimidazoles, method for the production thereof, their use as a medicament or as a diagnostic reagent, and medicament containing these compounds

2004208861-3-phenyl substituted 3-substituted-4-ketolactams and ketolactones